Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin ; volume:19 ; number:1 ; day:12 ; month:2 ; year:2021 ; pages:1-11 ; date:12.2021
Cell communication and signaling ; 19, Heft 1 (12.2.2021), 1-11, 12.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-020-00702-x
- URN
-
urn:nbn:de:101:1-2021040308511270589397
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roser, Christoph
- Tóth, Csaba
- Renner, Marcus
- Herpel, Esther
- Schirmacher, Peter
- SpringerLink (Online service)
Other Objects (12)
Pathogenesis of human hepatocellular carcinoma
Pemigatinib : erste zielgerichtete Zweitlinientherapie beim Cholangiokarzinom mit FGFR2-Fusion/Rearrangement
Molecular diagnostics of hepatobiliary and pancreatic neoplasias
Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases
Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas
Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling
Surveillance of duodenal adenomas in familial adenomatous polyposis patients: medical objectives and technical requirements
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course
Pathogenesis of human hepatocellular carcinoma
Pemigatinib : erste zielgerichtete Zweitlinientherapie beim Cholangiokarzinom mit FGFR2-Fusion/Rearrangement
Molecular diagnostics of hepatobiliary and pancreatic neoplasias
Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases
Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas
Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling
Surveillance of duodenal adenomas in familial adenomatous polyposis patients: medical objectives and technical requirements
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course
Pathogenesis of human hepatocellular carcinoma
Pemigatinib : erste zielgerichtete Zweitlinientherapie beim Cholangiokarzinom mit FGFR2-Fusion/Rearrangement
Molecular diagnostics of hepatobiliary and pancreatic neoplasias
Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases
Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas
Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling
Surveillance of duodenal adenomas in familial adenomatous polyposis patients: medical objectives and technical requirements
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study